{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:19:59Z","timestamp":1754151599191,"version":"3.41.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,19]]},"DOI":"10.7759\/cureus.88297","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T12:53:51Z","timestamp":1752929631000},"source":"Crossref","is-referenced-by-count":0,"title":["Pregabalin as a Potential Adjunct in the Management of Pruritus in Prurigo Nodularis: A Case Report"],"prefix":"10.7759","author":[{"given":"Yoshihito","family":"Mima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka T","year":"2017","unstructured":"Ruzicka T, Hanifin JM, Furue M, et al.. Anti-interleukin-31 receptor A antibody for atopic dermatitis. N Engl J Med. 2017, 376:826-35. 10.1056\/NEJMoa1606490","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.182","article-title":"Prurigo nodularis: pathogenesis and management","volume":"83","author":"Williams KA","year":"2020","unstructured":"Williams KA, Huang AH, Belzberg M, Kwatra SG. Prurigo nodularis: pathogenesis and management. J Am Acad Dermatol. 2020, 83:1567-75. 10.1016\/j.jaad.2020.04.182","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2018.02.003","article-title":"Prurigo nodularis and its management","volume":"36","author":"Zeidler C","year":"2018","unstructured":"Zeidler C, Yosipovitch G, St\u00e4nder S. Prurigo nodularis and its management. Dermatol Clin. 2018, 36:189-97. 10.1016\/j.det.2018.02.003","journal-title":"Dermatol Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly E","year":"2006","unstructured":"Sonkoly E, Muller A, Lauerma AI, et al.. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006, 117:411-7. 10.1016\/j.jaci.2005.10.033","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae052","article-title":"Prurigo nodularis: new insights into pathogenesis and\u00a0novel therapeutics","volume":"190","author":"Liao V","year":"2024","unstructured":"Liao V, Cornman HL, Ma E, Kwatra SG. Prurigo nodularis: new insights into pathogenesis and\u00a0novel therapeutics. Br J Dermatol. 2024, 190:798-810. 10.1093\/bjd\/ljae052","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093026","article-title":"Cutaneous adverse events following nemolizumab administration: a review","volume":"14","author":"Mima Y","year":"2025","unstructured":"Mima Y, Yamamoto M, Iozumi K. Cutaneous adverse events following nemolizumab administration: a review. J Clin Med. 2025, 14:6. 10.3390\/jcm14093026","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.0060","article-title":"Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess","volume":"52","author":"Imai K","year":"2013","unstructured":"Imai K, Kishimoto M, Tsujimoto T, et al.. Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess. Intern Med. 2013, 52:2629-33. 10.2169\/internalmedicine.52.0060","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12005","article-title":"Treatment of prurigo nodularis with pregabalin","volume":"38","author":"Mazza M","year":"2013","unstructured":"Mazza M, Guerriero G, Marano G, Janiri L, Bria P, Mazza S. Treatment of prurigo nodularis with pregabalin. J Clin Pharm Ther. 2013, 38:16-8. 10.1111\/jcpt.12005","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor CP","year":"2007","unstructured":"Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007, 73:137-50. 10.1016\/j.eplepsyres.2006.09.008","journal-title":"Epilepsy Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620080-00010","article-title":"Pregabalin: in the treatment of generalised anxiety disorder","volume":"20","author":"Frampton JE","year":"2006","unstructured":"Frampton JE, Foster RH. Pregabalin: in the treatment of generalised anxiety disorder. CNS Drugs. 2006, 20:685-93. 10.2165\/00023210-200620080-00010","journal-title":"CNS Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17551","article-title":"Efficacy and safety of pregabalin versus gabapentin among chronic pruritus patients: a randomized study","volume":"64","author":"Saravanan A","year":"2025","unstructured":"Saravanan A, Anil A, Bhardwaj A, et al.. Efficacy and safety of pregabalin versus gabapentin among chronic pruritus patients: a randomized study. Int J Dermatol. 2025, 64:762-4. 10.1111\/ijd.17551","journal-title":"Int J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28553","article-title":"Frontiers in pruritus research: scratching the brain for more effective itch therapy","volume":"116","author":"Paus R","year":"2006","unstructured":"Paus R, Schmelz M, B\u00edr\u00f3 T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006, 116:1174-86. 10.1172\/JCI28553","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.10173fp","article-title":"Gabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice","volume":"115","author":"Tsukumo Y","year":"2011","unstructured":"Tsukumo Y, Matsumoto Y, Miura H, Yano H, Manabe H. Gabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice. J Pharmacol Sci. 2011, 115:27-35. 10.1254\/jphs.10173fp","journal-title":"J Pharmacol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57629-z","article-title":"Efficacy of pregabalin for the treatment of chronic pruritus of unknown origin, assessed based on electric current perception threshold","volume":"10","author":"Lee J","year":"2020","unstructured":"Lee J, Jang D, Bae J, Jung H, Park M, Ahn J. Efficacy of pregabalin for the treatment of chronic pruritus of unknown origin, assessed based on electric current perception threshold. Sci Rep. 2020, 10:1022. 10.1038\/s41598-020-57629-z","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2024.08.028","article-title":"Efficacy and safety of pregabalin and gabapentin for pruritus: a systematic review and meta-analysis","volume":"69","author":"Xu W","year":"2025","unstructured":"Xu W, Dong H, Ran H, Liu H, Wang L, Li H, Tan C. Efficacy and safety of pregabalin and gabapentin for pruritus: a systematic review and meta-analysis. J Pain Symptom Manage. 2025, 69:65-81. 10.1016\/j.jpainsymman.2024.08.028","journal-title":"J Pain Symptom Manage"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0806","article-title":"Disease mechanisms in neuropathic itch","volume":"4","author":"Binder A","year":"2008","unstructured":"Binder A, Koroschetz J, Baron R. Disease mechanisms in neuropathic itch. Nat Clin Pract Neurol. 2008, 4:329-37. 10.1038\/ncpneuro0806","journal-title":"Nat Clin Pract Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.02.1237","article-title":"Gabapentin and pregabalin for the treatment of chronic pruritus","volume":"75","author":"Matsuda KM","year":"2016","unstructured":"Matsuda KM, Sharma D, Schonfeld AR, Kwatra SG. Gabapentin and pregabalin for the treatment of chronic pruritus. J Am Acad Dermatol. 2016, 75:619-25.e6. 10.1016\/j.jaad.2016.02.1237","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3959(03)00173-8","article-title":"Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C","volume":"105","author":"Fehrenbacher JC","year":"2003","unstructured":"Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 2003, 105:133-141. 10.1016\/s0304-3959(03)00173-8","journal-title":"Pain"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00513-z","article-title":"Gabapentinoids for pruritus in older adults: a narrative review","volume":"11","author":"Sreekantaswamy SA","year":"2021","unstructured":"Sreekantaswamy SA, Mollanazar N, Butler DC. Gabapentinoids for pruritus in older adults: a narrative review. Dermatol Ther (Heidelb). 2021, 11:669-79. 10.1007\/s13555-021-00513-z","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392383-pregabalin-as-a-potential-adjunct-in-the-management-of-pruritus-in-prurigo-nodularis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T12:53:51Z","timestamp":1752929631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392383-pregabalin-as-a-potential-adjunct-in-the-management-of-pruritus-in-prurigo-nodularis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.88297","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,19]]}}}